Annual Stern Healthcare Association Conference

Transforming healthcare Delivery


Join us for the 2018 Stern Healthcare Association Conference on October 26th, 2018. The mission of our conference is to create a forum for issues and trends affecting the healthcare industry. This year, we will discuss how insurers, providers, pharmaceutical companies, and startups are responding to demands to develop precision medicine, provide value-based care, and stem cost escalation. Our goal is to examine the industry through multiple lenses and paint a holistic picture of the increasingly patient-centric healthcare landscape. The conference will highlight speakers from Aetna, Johnson & Johnson, Sanofi, Memorial Sloan Kettering Cancer Center, and the Icahn School of Medicine at Mount Sinai to name a few.

Last year's conference drew about 150 attendees, ranging from full-time and part-time students from several schools in the area to industry professionals. The conference showcased a wide variety of programming in 2017, including an entrepreneurship panel and talks given by executives at Boehringer Ingelheim and Bristol-Myers Squibb.

 

 

Friday, October 26th, 2018

NYU Stern School of Business

Kaufman Management Center

44 West 4th Street

New York, NY 10012

1:00 PM - 7:00 PM


Event Schedule

Registration
Kaufman Management Center (KMC) Lobby  
1:00 PM - 1:30 PM

Opening Address
Karen Weinseiss, SVP of International Health Management, Aetna International KMC 5-50 
1:45 PM - 2:30 PM

Panel: Provider Innovations in Focus Melissa Aldridge, Icahn School of Medicine at Mount Sinai Andrew Isaacs, StartUp Health Ventures Christy Manso, Memorial Sloan Kettering Cancer Center Michael Dickstein, New York University Stern School of Business
KMC 1-70 
2:40 PM - 3:40 PM

Coffee Break*
KMC 5-50
3:40 PM - 4:10 PM

*Beverages and light refreshments to be provided

Panel: Adapting to the Future of Pharmaceuticals Raj Arora, Sanofi Yoni Falkson, Regeneron Pharmaceuticals Sangeetha Ramsagar, Johnson & Johnson Rishi Jaggernauth, Regeneron Pharmaceuticals
KMC 1-70 
4:10 PM - 5:10 PM

Closing Address
Adele Gulfo, Chief of Commercial Development, Roivant Sciences KMC 5-50
5:20 PM - 6:00 PM

Networking Reception
KMC 1-100
6:10 PM - 7:10 PM

 


Conference Speakers

Karen.jpg

Karen Weinseiss SVP of International Health Management Aetna International

Karen Weinseiss leads Aetna International’s Health Management teams. These clinical, provider network, data science and medical cost containment teams provide best in class solutions that position Aetna as a global leader in international health, addressing the growing globally mobile population and the growing demand for comprehensive health solutions.

Prior to International, Karen held roles in Aetna’s U.S. domestic National Care Management, Product, Innovation, as well as, Marketing organizations. Karen joined Aetna in 2006 bringing more than a dozen years of experience in product management, marketing, sales, business development, and operations. Preceding Aetna, she worked at Creative Solutions Group, a boutique employee benefits consultant house. She also held numerous positions at GE Capital, including business development assignments on the local and national level, as well as on the international stage, taking extended assignments in Mexico, Austria, Hungary, and the Czech Republic.

Karen holds an MBA in International Business and Finance from NYU’s Stern School of Business and a Bachelors in Economics and German from Rutgers University.

Adele.jpg

Adele Gulfo Chief of Commercial Development Roivant Sciences

Adele Gulfo has served as Chief of Commercial Development at Roivant Sciences since May 2018. Ms. Gulfo previously served as President and General Manager of Pfizer’s $12B+ US primary care business unit, comprised of over 5,000 employees across multiple therapeutic areas. She also ran Pfizer’s Commercial Operations, and as US Country Chair led the Managed Care organization across all biopharmaceutical businesses, including Specialty, Oncology, and Vaccines. Ms. Gulfo was Pfizer’s President of Latin America, where she led a team of over 4,000 colleagues across 24 countries. Most recently, she was Executive Vice President, Chief Strategy Officer, and Head of Global Commercial Development at Mylan. Prior to joining Pfizer, she spent 9 years at AstraZeneca where she held senior leadership roles in Business Development, Strategy and Healthcare Innovation, and ran the company’s Cardiovascular business unit where she oversaw the successful launch of CRESTOR®.

Before joining AstraZeneca, Ms. Gulfo planned and executed the launch and commercial strategy for LIPITOR®, the world’s most successful branded medicine which achieved market leadership within two years of launch. Trained as a scientist, she has been awarded six U.S. patents for novel medication packaging adherence tools and an allergy treatment. She holds a Bachelor of Science degree in biology from Seton Hall University and an MBA with highest honors from Fairleigh Dickinson University. She studied post-graduate Molecular Biology and began her career at the University of Medicine and Dentistry of New Jersey.

Melissa.jpg

Melissa D. Aldridge Associate Professor Icahn School of Medicine at Mount Sinai

Melissa D. Aldridge, PhD, MBA, MPH, is an Associate Professor and Vice-Chair for Research in the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Aldridge is a health services researcher with expertise in the use of large, national, survey and administrative databases. Her research focuses on patterns of hospice use, transitions in care at the end of life, and the financial incentives inherent in the Medicare Hospice Benefit payment structure. She is particularly interested in the effect of hospice organizational characteristics (for-profit ownership, size) on the quality of care delivered to patients and families. Dr. Aldridge leads the Population Research and Effectiveness Core for Mount Sinai’s Claude D. Pepper Older American Independence Center and NPCRC’s junior faculty research technical assistance program, which encompasses the pre-Foley retreat research methods workshops, webinars, grant review program, and research consultancy program.

Andrew.jpg

Andrew Isaacs Head of Ventures StartUp Health

Andrew Isaacs is Head of Ventures at StartUp Health where he focuses on venture strategy and investments in early stage healthcare technology and services companies.

Previously, Andrew worked at Evercore Partners and Morgan Stanley where he specialized in M&A advisory across the healthcare services industry. While there, Andrew advised companies in identifying, evaluating and executing on a variety of capital and strategic alternatives. Andrew began his career at KPMG in the Financial Risk Advisory group.

Andrew is a Managing Director at Acacia Capital Partners, a boutique strategic advisory firm, where he specializes in advising early stage healthcare and blockchain companies across all aspects of their growth strategies.

Andrew holds an MBA from The University of Chicago Booth School, as well as a B.Comm. (Honors) in Accounting from the University of Johannesburg. Andrew is a qualified Chartered Accountant and registered member of the South African Institute of Chartered Accountants and FINRA.

Christy.jpg

Christy Manso Regional Community Program Manager Memorial Sloan Kettering Cancer Center

Christy Manso is the Regional Community Program Manager at Memorial Sloan Kettering Cancer Center where she manages corporate and community engagement for MSK’s network of regional outpatient locations. Previously, Christy was a Clinical Practice Supervisor at MSK’s Rockefeller Outpatient Pavilion where she managed the operations of several busy outpatient clinics – a career change that was prompted after spending time caring for family members with cancer.

In her free time, Christy volunteers for the American Cancer Society Cancer Action Network – the advocacy affiliate of the American Cancer Society. She served for two years as New York State Lead Ambassador for ACS CAN and is currently the New York State Training Lead, on-boarding new advocacy volunteers. Christy graduated with an MBA from NYU’s Stern School of Business in 2007.

Michael.jpeg

Michael Dickstein Assistant Professor of Economics New York University Stern School of Business

Michael Dickstein is an assistant professor of economics at New York University’s Stern School of Business. Professor Dickstein’s research focuses on the industrial organization of health care markets.  In recent work, he has investigated Medicare’s price-setting for physician services, the design of individual health insurance marketplaces, and the mechanisms through which physicians learn about new drug treatments.

Prior to joining NYU Stern, Professor Dickstein was an assistant professor of economics at Stanford University and a postdoctoral associate at the Cowles Foundation at Yale University.  He holds a Ph.D. in business economics from Harvard University and a B.S. in applied economics from Cornell University.

Raj.jpg

Raj Arora Director of Strategic Pricing Sanofi

Raj Arora is Director of Strategic Pricing at Sanofi based in Bridgewater, NJ. At Sanofi, Raj leads pricing and contracting strategy for Joint Health, Multi-source/Generic, and Blood disorder product portfolio. Prior to his current role, Raj has held roles with increasing responsibilities in sales forecasting, business development, finance, technology solutions and strategy consulting.

Raj holds MBA in Finance and Strategy from New York University’s Stern School of Business.

Yoni.jpg

Yoni Falkson Director of New Products Planning Regeneron Pharmaceuticals

Yoni recently joined the New Products Planning team at Regeneron where he is the commercial lead for multiple early stage rare, metabolic and immunology programs. Prior to Regeneron, Yoni cofounded SpringWorks Therapeutics and led Commercial Development and Operations for 4 mid/late stage rare disease programs (spun out from Pfizer). Before developing the SpringWorks business model and raising capital, Yoni worked in Pfizer’s Global Early Commercial Development group focused on the CV/Metabolic pipeline. Earlier in his career Yoni spent a number of years as a Global Market Access consultant at IMS, and led the global market access launch of Eliquis for Atrial fibrillation and US Payer strategy for Butrans for moderate to Severe chronic pain.

Yoni holds a degree in economics and psychology from Cornell and an MBA from NYU Stern.

Sangeetha.jpg

Sangeetha Ramsagar Director of Strategic Business Improvement Johnson & Johnson

Sangeetha Ramsagar holds the position of Director of Strategy at Johnson & Johnson. She is the former Director for Precision Medicine Commercialization at Bayer Pharmaceuticals and is experienced in drug lifecycle management and drug launches. She has 15+ years of experience in drug pipeline and inline commercial strategy and is recognized in the pharmaceutical and diagnostic community as a moderator, interviewer, and co-host of health care and precision medicine panels and events, showcased worldwide.

Rishi.jpg

Rishi Jaggernauth Business Leadership Development Program Associate Regeneron Pharmaceuticals

Rishi Jaggernauth is a Business Leadership Development Program Associate at Regeneron Pharmaceuticals. Prior to joining Regeneron, Rishi was a William R. Berkley Scholar at NYU Stern and graduated from the MBA program with distinction in 2017. Prior to Stern, Rishi held various roles in the biotechnology space, working in equity research at the investment bank Oppenheimer & Co and in business development at the biotech startup Desktop Genetics. Rishi holds a Bachelor of Science in Biotechnology with a specialization in Bioscience Policy and Management from Rutgers University and was named a "Leader of Tomorrow" at the 2017 St. Gallen Symposium. 


Stern Healthcare Association Sponsors

image_124919_regeneron_logo_103145739.jpg
flyer_image_upload_542025_iqvia_917124042.jpg
Pfizer_logo-880x660.png

Companies interested in sponsorship or participating in the networking reception please contact sha@stern.nyu.edu


Like what you're reading and want to see more?


FAQ

Where will the conference take place?

The conference will be held on the NYU Stern campus in Kaufman Management Center located at 44 West 4th Street. 

Where should I check-in?

Check-in will take place in the lobby of Kaufman Management Center. Upon entering the building from Gould Plaza walk to the left toward the main security desk. Please bring a photo ID. Once through security, you will see a check-in table and signs for the event in the lobby. Attendants at the check-in desk will direct you where to go depending on your time of arrival.

I'm a Prospective/undergraduate Student, can I attend?

Of course! We'd love for you to join us at conference to learn more about NYU and the Stern Healthcare Association. Please email Andrew Liang at al3417@stern.nyu.edu for additional details.

Directions:

The NYU Stern campus (44 West 4th Street) is easily accessible by public transportation (A,B,C,D, E, F or M at West 4th Street; N or R at 8th St-NYU or the 6 at Astor Place). If you are traveling by car, public parking is available on West 3rd Street and on Thompson Street.

 

Pictures from last year's conference:


ABOUT US...

Questions?

Email sha@stern.nyu.edu

SHA aims to bring together Stern MBA students who have an interest in the healthcare industries. Our objectives include:

  • Promoting the advancement of health care, pharmaceutical science, and biotechnology and understand the issues and challenges facing these industries

  • Helping members explore the career opportunities within these sectors

  • Increasing the academic awareness and student interest in these dynamic industries

  • Serving as a recruitment connection for all healthcare related professions, including pharmaceutical, biotechnology and medical device firms as well as healthcare related professional service firms in consulting and finance.